29: Hydroxychloroquine – Potentially toxic, p...

Ahead of Sound Optometry’s return in January 2027, we’re revisiting some highlights from our sixty-episode archive. In the second bonus podcast, we’re exploring the dilemma associated with discovering new ocular lesions. In 2021, Michelle Hanratty and Professor Heinrich Heimann, ...  Show more

Ahead of Sound Optometry’s return in January 2027, we’re revisiting some highlights from our sixty-episode archive. In the first bonus podcast, we’re exploring how to detect and manage papilloedema. Back in 2020, Michelle Hanratty was joined by Naz Raoof, a neuro-ophthalmologist ...  Show more

Dr. Edmund Tsui interviews authors Dr. Muhammad Z. Chauhan and Dr. Krishna S. Kishor on the risk of uveitis among patients starting topical glaucoma therapy. From their Ophthalmology Glaucoma article, "<a href= "https://www.ophthalmologyglaucoma.org/ ...

In this episode, Robert J. Noecker, MD, reviews the role of preservatives, particularly benzalkonium chloride (BAK), in ophthalmic medications. While BAK effectively prevents bacterial growth, its inherent toxicity poses challenges with prolonged use, leading to symptoms associat ...  Show more

Dr. Drew Carey interviews medical student Jawad Muayad and Dr. Sami S. Dahr on the impact of systemic medications, including glucagon-like peptide-1 receptor agonists, fenofibrates, thiazolidinediones, and calcium channel blockers, on the risk of developing diabetic macular edema ...  Show more